Cargando…

Insulin Resistance and Genetic Risk Predict Liver‐Related Outcomes and Death in Nonalcoholic Fatty Liver Disease

A pathophysiologic risk score consisting of insulin resistance and genetic risk predicts incident liver outcomes in NAFLD. Such scores may represent a viable strategy for risk stratification in NAFLD.[Image: see text]

Detalles Bibliográficos
Autores principales:	Danford, Christopher J., Jiang, Z. Gordon, Salomaa, Veikko, Färkkilä, Martti, Jula, Antti, Männistö, Satu, Lundqvist, Annamari, Valsta, Liisa, Perola, Markus, Åberg, Fredrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887916/ https://www.ncbi.nlm.nih.gov/pubmed/31832576 http://dx.doi.org/10.1002/hep4.1437

Ejemplares similares

Serum lipopolysaccharides predict advanced liver disease in the general population
por: Männistö, Ville, et al.
Publicado: (2019)

Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use
por: Åberg, Fredrik, et al.
Publicado: (2023)

Comparison of various strategies to define the optimal target population for liver fibrosis screening: A population‐based cohort study
por: Åberg, Fredrik, et al.
Publicado: (2022)

Association between arterial hypertension and liver outcomes using polygenic risk scores: a population-based study
por: Åberg, Fredrik, et al.
Publicado: (2022)

Enhanced liver Fibrosis® test predicts liver-related outcomes in the general population
por: Saarinen, Kustaa, et al.
Publicado: (2023)

A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease
por: Åberg, Fredrik, et al.
Publicado: (2021)

Links between gut microbiome composition and fatty liver disease in a large population sample
por: Ruuskanen, Matti O., et al.
Publicado: (2021)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2018)

24-h urinary sodium excretion and the risk of adverse outcomes
por: Vuori, Matti A., et al.
Publicado: (2020)

Fish Consumption and Omega-3 Polyunsaturated Fatty Acids in Relation to Depressive Episodes: A Cross-Sectional Analysis
por: Suominen-Taipale, Anna Liisa, et al.
Publicado: (2010)

Nonalcoholic fatty liver disease and insulin resistance in children
por: Song, Kyungchul, et al.
Publicado: (2023)

Bayesian Variable Selection in Searching for Additive and Dominant Effects in Genome-Wide Data
por: Peltola, Tomi, et al.
Publicado: (2012)

Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study
por: Jousilahti, Pekka, et al.
Publicado: (2016)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
por: Jelenik, Tomas, et al.
Publicado: (2017)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Conlon, Beth A., et al.
Publicado: (2013)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

The association of high-sensitivity C-reactive protein with future weight gain in adults
por: Santa-Paavola, Riina, et al.
Publicado: (2022)

Naturally occurring and added sugar in relation to macronutrient intake and food consumption: results from a population-based study in adults
por: Kaartinen, Niina E., et al.
Publicado: (2017)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Hepatic Notch Signaling Correlates With Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
por: Kawanaka, Miwa, et al.
Publicado: (2015)

Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease
por: Britton, Laurence, et al.
Publicado: (2018)

Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
por: Dali‐Youcef, Nassim, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Thrombocytopenia III: Its Association With Insulin Resistance
por: López-Trujillo, Miguel Antonio, et al.
Publicado: (2019)

Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
por: Vittal, Anusha, et al.
Publicado: (2020)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bsmotf3bnlffdg5eib3jpoacpd